Clinical Trial Update: Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating physiological and high-dose estradiol for hormone receptor-positive metastatic breast cancer has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ESTRADIOL (Estradiol)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2015-02-16